Research and discoveries

Find a researcher

ICR divisions

Centres and strategic collaborations

Our facilities and technology

Cancer discovery news

Cancer blogs

Our Research

ICR divisions Breast cancer research Cancer biology Cancer therapeutics Clinical studies Genetics and epidemiology Molecular pathology Radiotherapy and imaging Structural biology

Our facilities and technology Breast Cancer Now Nina Barough Pathology Core Facility Baculovirus Facility Light Microscopy Facility Electron Microscopy Facility Flow Cytometry Facility Mechanical Workshop and 3D Printing Proteomics Core Facility Scientific Computing Service Genomics Facility X-ray Crystallography Facility

Cancer discovery news Types of cancer Media office

Cancer blogs Lab research blogs The Darwin Cancer Blog

Our Research ICR research themes Our research excellence Academic excellence Animal research Data Science Drug and therapeutic discovery

Study and careers

PhDs for science graduates

Opportunities for clinicians

Student life and support

Undergraduate Summer Scholarship Scheme

Support moving to the UK

Careers at the ICR

Working life and benefits

PhDs for science graduates Our PhD projects Our PhD application process PhD FAQs and funding Contact student admissions PhDs and training news

Opportunities for clinicians MSc in Oncology PhD and MD(Res) for clinicians NIHR academic training Radiotherapy and imaging training courses

Student life and support Tuition fees Accommodation support Social life and welfare Academic and career support Student resources Student stories Alumni stories

Careers at the ICR Postdocs Research scientists Group leaders Clinicians Professional Service roles Contact careers team

Working life and benefits Staff benefits World-leading working facilities Equality and social groups Career development Employee stories

Industry partnerships

Partnership opportunities

Consultancy in oncology

Why partner with us

Our therapeutic pipeline

Industry partner news

London Cancer Hub

Contact our partner team

Why partner with us Our partnership philosophy The Innovation Gateway Entrepreneurs-in-residence Spin-out companies Enterprise events Our treatment and technology successes

About us

Our achievements

Funding and spending

Our strategy

Our history

ICR news

Patient stories

Corporate reports and policies

Leadership and governance

Contact us

ICR and the Royal Marsden

Our achievements Characterising the BRAF gene Transforming prostate cancer treatment Advanced radiotherapy techniques Identifying a breast cancer gene Targeting Hsp90 How cells become cancerous The function of the thymus Practice changing clinical trials in radiotherapy and imaging DNA damage and cancer Identifying cancer predisposition genes Applying evolutionary biology to cancer Transforming treatment for the most common type of breast cancer Developing the Pharmacological Audit Trail Discovering early chemotherapy drugs Discovering and developing a leading PI3K inhibitor Applying genetic principles to treatment of BRCA-mutant cancers Carcinogens in cigarette smoke

Our strategy Strategic partners Our values Equality and diversity Responsibility and sustainability

Corporate reports and policies Annual reports Improving access to clinical trials Improving drug access Use of biomarkers in cancer research and treatment Public engagement Our policy priorities

Leadership and governance Our leadership team Executive board Board of trustees Corporate governance ICR committees

Support us

Making a donation

Fundraising

Leave a legacy

Philanthropy

Corporate partnerships

Family charity partners

Our appeals

Search newsletter

Making a donation Why donate to the ICR How is my money spent Contact our donations team Donor stories Payroll giving Gift Aid

Fundraising How to fundraise with us Sport events and challenges Fundraising news Supporter stories Share your story Volunteer at our events

Leave a legacy Create a Will for free Donate in memory Information for executors The National Free Wills Network

Philanthropy How philanthropy supports our research Our philanthropic activity

Our appeals Help more women survive cancer Hard to treat cancers Childhood cancers Combination treatments Prostate cancer appeal Let's finish cancer Monthly gift for cancer patients

Search:

Research and discoveries

Study and careers

Industry partnerships

About us

Support us

See all hubs

Research and discoveries

Find a researcher

ICR divisions

Centres and strategic collaborations

Our facilities and technology

Cancer discovery news

Cancer blogs

Our Research

See all hubs

Study and careers

PhDs for science graduates

Opportunities for clinicians

Student life and support

Undergraduate Summer Scholarship Scheme

Support moving to the UK

Careers at the ICR

Working life and benefits

See all hubs

Industry partnerships

Partnership opportunities

Consultancy in oncology

Why partner with us

Our therapeutic pipeline

Industry partner news

London Cancer Hub

Contact our partner team

See all hubs

About us

Our achievements

Funding and spending

Our strategy

Our history

ICR news

Patient stories

Corporate reports and policies

Leadership and governance

Contact us

ICR and the Royal Marsden

See all hubs

Support us

Making a donation

Fundraising

Leave a legacy

Philanthropy

Corporate partnerships

Family charity partners

Our appeals

Search newsletter

See Research and discoveries

Find a researcher

Publications

See Research and discoveries

ICR divisions

Breast cancer research

Cancer biology

Cancer therapeutics

Clinical studies

Genetics and epidemiology

Molecular pathology

Radiotherapy and imaging

Structural biology

See Research and discoveries

Our facilities and technology

Breast Cancer Now Nina Barough Pathology Core Facility

Baculovirus Facility

Light Microscopy Facility

Electron Microscopy Facility

Flow Cytometry Facility

Mechanical Workshop and 3D Printing

Proteomics Core Facility

Scientific Computing Service

Genomics Facility

X-ray Crystallography Facility

See Research and discoveries

Cancer discovery news

Types of cancer

Media office

See Research and discoveries

Cancer blogs

Lab research blogs

The Darwin Cancer Blog

See Research and discoveries

Our Research

ICR research themes

Our research excellence

Academic excellence

Animal research

Data Science

Drug and therapeutic discovery

See Study and careers

PhDs for science graduates

Our PhD projects

Our PhD application process

PhD FAQs and funding

Contact student admissions

PhDs and training news

See Study and careers

Opportunities for clinicians

MSc in Oncology

PhD and MD(Res) for clinicians

NIHR academic training

Radiotherapy and imaging training courses

See Study and careers

Student life and support

Tuition fees

Accommodation support

Social life and welfare

Academic and career support

Student resources

Student stories

Alumni stories

See Study and careers

Careers at the ICR

Postdocs

Research scientists

Group leaders

Clinicians

Professional Service roles

Contact careers team

See Study and careers

Working life and benefits

Staff benefits

World-leading working facilities

Equality and social groups

Career development

Employee stories

See Industry partnerships

Why partner with us

Our partnership philosophy

The Innovation Gateway

Entrepreneurs-in-residence

Spin-out companies

Enterprise events

Our treatment and technology successes

See Industry partnerships

Contact our partner team

Connections newsletter

See About us

Our achievements

Characterising the BRAF gene

Transforming prostate cancer treatment

Advanced radiotherapy techniques

Identifying a breast cancer gene

Targeting Hsp90

How cells become cancerous

The function of the thymus

Practice changing clinical trials in radiotherapy and imaging

DNA damage and cancer

Identifying cancer predisposition genes

Applying evolutionary biology to cancer

Transforming treatment for the most common type of breast cancer

Developing the Pharmacological Audit Trail

Discovering early chemotherapy drugs

Discovering and developing a leading PI3K inhibitor

Applying genetic principles to treatment of BRCA-mutant cancers

Carcinogens in cigarette smoke

See About us

Our strategy

Strategic partners

Our values

Equality and diversity

Responsibility and sustainability

See About us

Corporate reports and policies

Annual reports

Improving access to clinical trials

Improving drug access

Use of biomarkers in cancer research and treatment

Public engagement

Our policy priorities

See About us

Leadership and governance

Our leadership team

Executive board

Board of trustees

Corporate governance

ICR committees

See Support us

Making a donation

Why donate to the ICR

How is my money spent

Contact our donations team

Donor stories

Payroll giving

Gift Aid

See Support us

Fundraising

How to fundraise with us

Sport events and challenges

Fundraising news

Supporter stories

Share your story

Volunteer at our events

See Support us

Leave a legacy

Create a Will for free

Donate in memory

Information for executors

The National Free Wills Network

See Support us

Philanthropy

How philanthropy supports our research

Our philanthropic activity

See Support us

Our appeals

Help more women survive cancer

Hard to treat cancers

Childhood cancers

Combination treatments

Prostate cancer appeal

Let's finish cancer

Monthly gift for cancer patients

Charlotte Bayley

Honorary Appointment: Medicinal Chemistry 1

Email: [email protected]

Location: Sutton

Email: [email protected]

Location: Sutton

Home
Research and discoveries
Find a researcher

Related pages

Cancer therapeutics
Medicinal Chemistry 1

inpartnershipwith

Research and discoveries
Study and careers
Industry partnerships
About us
Support us

Contact us
Privacy
Terms and conditions
Accessibility
Purchasing
Conflict of interest in research
Modern slavery statement
Cookies

Copyright © 2024 The Institute of Cancer Research.

All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee.
Registered in England No. 534147. VAT Registration No. GB 849 0581 02.